DOI: 10.1055/s-00034916

Nervenheilkunde

LinksSchließen

Referenz

Jones PB. et al.
Randomized controlled trial of the effect on quality of life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).

Arch Gen Psychiatry 2006;
63 (Suppl. 10) 1079-1087.

Bibliographische Angaben herunterladen

Aufrufen in:
Aufrufen in: